Specifications
| Target | BCL9 |
| Reactivity | Human, Mouse |
| Applications | ELISA, IHC, WB |
| MW(Calculated) | |
| MW(Observed) | |
| Host Species | Rabbit |
| Isotype | IgG |
| Conjugate/Modification | Unmodified |
| Modification | |
| Recommended Dilution Ratio | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| Composition | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| Purification Process | Purified by antigen affinity column. |
| Purity | |
| Storage Condition | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Concentration | |
| Clonality | Polyclonal |
| Clone Number | |
| Immunogen | E. coli - derived recombinant human BCL9 (Gln170-Leu220). |
| Gene Name | |
| Protein Name | |
| Alias | B-cell CLL/lymphoma 9 protein; B-cell lymphoma 9 protein; Bcl-9; Protein legless homolog; BCL9 |
| Species | Human |
| Gene ID-1 | |
| Uniprot | O00512, Q9D219 |
| Species.1 | |
| Gene ID | |
| Uniprot.1 | |
| Species.2 | |
| Gene ID.1 | |
| Uniprot.2 | |
| Organism-4 | |
| Gene ID-4 | |
| SwissProt-4 | |
| Description | |
| Cellular Localization | |
| Tissue Expression | |
| Signaling_pathway | |
| Research Areas | |
| Function |
